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Botulism 
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Importance 
Botulism is caused by botulinum toxins, neurotoxins produced by Clostridium 
botulinum and a few other species of Clostridium. By binding to nerve endings, these 
toxins cause progressive flaccid paralysis in humans and animals. Many untreated 
cases end in death from paralysis of the respiratory muscles. C. botulinum spores are 
common in the environment, but they can germinate and grow only in anaerobic 
environments under specific conditions. Foodborne botulism results from the 
ingestion of the preformed toxin after the organism has grown in food. Botulinum-
producing organisms may also grow in the immature gastrointestinal tracts of human 
infants and foals, in human gastrointestinal tracts with certain abnormalities, and in 
anaerobic wounds. In addition, these toxins are a concern in bioterrorism.  
Sporadic cases and outbreaks of botulism occur in both humans and animals. 
This disease is an important cause of death in unvaccinated ranched mink, and it can 
cause large outbreaks among wild birds such as waterfowl and gulls. Livestock may 
be accidentally fed the toxin in contaminated feed. Botulism seems to be increasing in 
cattle, possibly due to the increased use of plastic-packaged grass silage, and these 
outbreaks can cause significant economic losses. Cattle in areas with phosphorus-
deficient soils may also chew on toxin-contaminated bones and scraps of flesh in the 
environment to satisfy the deficiency. In Senegal, which has such soils, botulism is 
thought to cause more deaths than any other cattle disease. In addition, botulinum has 
been reported in a variety of other species including poultry, dogs, cats, foxes, captive 
lions and sea lions, turtles, farmed fish and wild bighorn sheep. Botulism can be 
treated successfully, but patients may require weeks or months of intensive care, 
sometimes including mechanical ventilation, while the nerve endings regenerate. 
Treatment may be impractical in adult livestock unless the case is mild. 
Etiology 
Botulism is caused by botulinum toxin, a potent neurotoxin produced by 
Clostridium botulinum, a few strains of C. baratii and C. butyricum, and the recently 
reclassified species C. argentinense (formerly known as the type G toxin producing 
strains of C. botulinum). All of these organisms are anaerobic, Gram-positive, spore-
forming rods.  
The organisms that produce botulinum toxin are diverse, and can produce seven 
types of toxins (A through G). Researchers have also described a mosaic C/D toxin 
from outbreaks in birds. Most clostridial strains only produce one toxin type. All of 
the botulinum toxins cause the same clinical signs, although there may be some 
differences in the severity of the disease. However, knowing the toxin type is 
important in selecting an antiserum for treatment; antiserum produced against one 
type is not protective against others. Different toxin types also tend to cause botulism 
in different species. In people, botulism is usually caused by types A, B and E, 
although rare cases or outbreaks caused by types C, D, F and G have been described. 
Types C and D are the most common causes of disease in other mammals and birds, 
but types A, B and E can also be involved. Type C is especially common in birds, 
mink, horses in most parts of the world, cattle that have been fed poultry litter, and 
dogs that have eaten contaminated bird carcasses. Type C or type D may be found in 
livestock that have eaten feed contaminated with the carcasses of small animals. 
Types B and A are reported regularly from horses in the U.S., and can also affect 
other species. Type E toxin is often associated with aquatic environments, and can 
cause botulism in farmed rainbow trout (Oncorhynchus mykiss) and other fish, as well 
as in fish-eating birds. In addition to botulinum toxin, C. botulinum type C can 
produce a C2 toxin, which is an enterotoxin and causes gastrointestinal signs.  
The species C. botulinum is very diverse, and has been divided into four 
genotypically and phenotypically distinct groups. In humans, botulism is usually 
caused by group I or group II organisms. Group I contains proteolytic strains that 
produce toxins A, B or F, while group II consists of nonproteolytic strains that make 
B, E or F toxins. Group I and II C. botulinum strains differ in heat resistance (spores 
from group I organisms are more heat resistant), growth temperatures, and other 
characteristics, which can influence the types of foods where they tend to grow. 
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Group III C. botulinum strains, which produce toxins C or 
D, are usually associated with botulism in animals. Group 
IV C. botulinum produces the type G toxin and has been 
reclassified as the new species Clostridium argentinense. 
This organism has caused a single outbreak among humans 
in Switzerland. C. butyricum produces type E toxin, and C. 
baratii produces type F. 
Equine grass sickness 
Botulinum toxin has also been implicated in equine 
grass sickness, a neurodegenerative disease that occurs 
among grazing equids. This disease, which is often fatal, is 
seen most often in the United Kingdom, but it has also been 
reported from other locations. A very similar disease occurs 
in South America, where it is called mal seco. Equine grass 
sickness affects the gastrointestinal tract and some other 
organs, can be acute or chronic, and tends to be seen in 
young horses on pastures in the spring. Its cause is still 
uncertain, but C. botulinum toxins have been implicated. 
Geographic Distribution 
C. botulinum is found worldwide. Although botulism 
can occur anywhere, the distribution of the organism is not 
homogeneous, and cases tend to be more common in certain 
geographic areas. Environmental factors can also influence 
where botulism is seen. For example, this disease tends to 
common in cattle from areas with phosphorus-poor soils, 
such as those in southern Africa. 
The distribution of strains can also vary with the 
geographic area. In one study from the U.S., strains that 
produce type A toxin were detected mainly in neutral or 
alkaline soils in the western states, while type D-producing 
strains were found in some alkaline soils in these states. 
The distribution of type B strains was more uniform, but 
these organisms were especially common in the eastern 
states. Type C strains were detected in acidic soils in the 
Gulf Coast states. In North America, type E strains are most 
common along the shores of the Great Lakes and in the 
Pacific Northwest. In one study from the former U.S.S.R., 
strains that produced type E toxin accounted for 61% of the 
isolations. Knowing the toxin types that are prevalent in an 
area may be helpful in selecting an antitoxin, as this must 
often be done before the laboratory results are complete. 
Transmission 
All species of Clostridium can produce spores, dormant 
forms of the organism that are highly resistant to 
disinfectants, heat and environmental conditions that kill 
vegetative cells. These spores can survive for many years 
until favorable conditions allow them to germinate and 
grow. C. botulinum spores are common in the environment. 
In soil studies, this organism was detected in approximately 
18-23% of the samples in the U.S. and 10% of the samples 
in the former U.S.S.R. In addition to soils, C. botulinum can 
be found in sediments in lakes, streams and coastal waters. 
This organism has been reported from the intestinal tracts 
of some healthy fish, birds and mammals, and the gills and 
viscera of shellfish such as crabs. Botulinum toxin has been 
detected in snails, earthworms, maggots feeding on 
contaminated carcasses, and nematodes. Because 
invertebrates are not affected by the toxin, they can be 
important in transmitting it to species such as birds. 
The vegetative (active) form of C. botulinum can only 
grow and produce toxins under anaerobic conditions. A 
wide variety of plant and animal material can support its 
growth, but the conditions it needs are strict. In addition to 
the food or tissue being anaerobic, it must have a relatively 
high water content, the pH must be greater than 4.6, and 
ingredients such as salt or preservatives must not be present 
at high enough levels to inhibit germination and/or growth. 
Different strains or groups of C. botulinum may have 
somewhat different requirements. For instance, the acidity 
necessary to inhibit C. botulinum type C strains is reported 
to be pH 5.1 to 5.6, but other organisms can survive a lower 
pH. Each group also has an optimal, minimal and maximal 
temperature for growth. For example, some group II 
organisms may be able to grow in foods at refrigeration 
temperatures (3-4°C/ 37-39°F), but group I organisms and 
type C toxin-producing strains are inhibited. Because C. 
botulinum does not compete well with other 
microorganisms, growth is more likely to occur if other 
bacteria and molds have been killed or inhibited. C. 
botulinum spores can survive cooking and some food-
processing conditions that kill vegetative cells, then 
germinate and grow in the cooked food. 
Botulism usually occurs when people or animals ingest 
the toxins in food or water, or when the spores germinate in 
anaerobic tissues and produce toxins as they grow. 
Botulinum toxin does not pass through intact skin, but it 
can cross mucous membranes and broken skin. Laboratory 
accidents can cause botulism by inhalation or other means, 
and bioterrorism is a possibility. 
Botulism in humans 
In humans, the three major forms of disease are 
foodborne, wound, and infant or intestinal botulism. 
Foodborne botulism occurs when humans ingest preformed 
toxins in various foods. Modern industrial canning 
techniques were designed to kill C. botulinum spores, and 
most cases are caused by home-canned, low acid foods (pH 
> 4.6), as well as meat products such as sausages and ham, 
and fermented fish, seal and whale meat. However, many 
different foods can be involved if the conditions are 
favorable; botulism has been caused by products as diverse 
as yogurt, garlic oil and foil-wrapped baked potatoes. 
Baked foods that have been left at room temperature or in a 
warm oven overnight can cause this disease if the baking 
kills competing microorganisms, and anaerobic conditions 
occur in the interior of the food. Commercial foods are 
occasionally involved.  
Wound botulism occurs when an anaerobic wound is 
contaminated with C. botulinum, and the organism is able 
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to grow and produce toxin. Wound botulism is rare except 
in injecting drug abusers, where it is caused by 
contaminated needles or drugs. It is especially common 
among people who inject “black tar heroin” directly into the 
subcutaneous tissues. 
Infant botulism is seen in children less than a year of 
age. In this form, C. botulinum spores germinate in the 
intestinal tract and produce toxin. Infants are thought to be 
predisposed because their intestinal flora is immature and 
because they produce reduced amounts of bile acids, 
which inhibit clostridial organisms. Honey has been 
associated with some cases of infant botulism, but spores 
can also be found in many other sources including dust. 
Botulinum spores from the environment can be ingested 
by most older children and adults without harm; these 
spores simply pass through the intestines without 
germinating. However, there are rare cases of intestinal 
colonization botulism in people who have altered 
intestinal conditions from gastrointestinal surgery, 
intensive antibiotic therapy or abnormalities such as 
achlorhydria.  
Botulism can also occur from laboratory accidents 
(e.g., by inhalation or accidental injection of the toxin). The 
toxin is used therapeutically to treat some muscle 
movement disorders and other conditions, and a few cases 
of iatrogenic botulism have been reported.  
Botulism in animals 
Preformed toxins in a variety of sources including 
decaying vegetable matter (e.g., grass, hay, haylage, grain, 
spoiled silage), meat and fish, carcasses, invertebrates and 
contaminated water can cause botulism in animals. 
Carnivores are usually fed the toxins in contaminated 
meat or fish, or ingest the toxins in carcasses (possibly 
including iguanas) or decaying, high protein garbage. 
Cattle in phosphorus-deficient areas may develop pica and 
chew bones and scraps of attached meat; a gram of dried 
flesh may have enough botulinum toxin to kill a cow. 
Similar cases occur in Australia, where protein-deficient 
sheep sometimes eat the carcasses of rabbits and other 
small animals. Herbivores also become ill when they are 
fed the toxin in forage such as hay or insufficiently 
acidified silage. These feeds may be contaminated by the 
toxin-containing carcasses of birds and mammals, or from 
other sources of C. botulinum. The feeding of poultry 
litter containing type C spores has been linked to some 
outbreaks in ruminants. Birds can ingest botulinum toxins 
in maggots that have fed on contaminated carcasses or 
invertebrates from water with decaying vegetation. Fish 
have been suggested as the source of the toxin in some 
outbreaks among birds. Contaminated feed can also result 
in cases in poultry. In addition, botulism has been 
described in animals that drank water contaminated by a 
carcass or other source of toxin. 
The toxicoinfectious form of botulism in animals 
corresponds to the wound and intestinal forms in humans. 
Similarly to human infants, botulism in foals (the shaker 
foal syndrome) seems to be caused by the growth of C. 
botulinum in the gastrointestinal tract. Rare cases of 
wound botulism have been seen in some species such as 
horses. Toxicoinfectious botulism is also seen in chickens, 
when broilers are intensively reared on litter; the cause of 
this phenomenon is unknown.  
Botulism is not contagious by casual contact, but it can 
be transmitted between animals by predation or 
cannibalism. Contaminated foods usually contain spores as 
well as the toxin. Spores that are passing through the 
gastrointestinal tract may germinate and grow if the animal 
dies. This can perpetuate the cycle, and may result in large 
outbreaks in birds or other species. Outbreaks of botulism 
can also contaminate the environment with spores, making 
future outbreaks more likely.  
Botulinum and Bioterrorism 
In a bioterrorist attack, botulinum toxin could be 
delivered by aerosols, as well as in food or water. 
Aerosolization is the most likely form. After aerosol 
transmission, the clinical disease is expected to be similar to 
foodborne botulism. 
Disinfection/Inactivation 
Botulinum toxins are large, easily denatured proteins. 
Toxins exposed to sunlight are inactivated within 1 to 3 
hours. They can also be inactivated by treating with 0.1% 
sodium hypochlorite or 0.1 N NaOH, as well as by heating 
to 80°C (176°F) for 20 minutes or to greater than 85°C 
(185°F) for at least 5 minutes. The toxin’s heat resistance 
varies with the medium, its pH and the concentration of the 
toxin. In beef broth, type E toxin was reported to be 
inactivated within 1 to 9 minutes at 80°C (176°F), with the 
longest survival time at pH 5.0 and the shortest survival 
time at the pH extremes (pH 3.5 or 6.8). The World Health 
Organization (WHO) recommends boiling food for a few 
minutes to inactivate botulinum toxins. Chlorine and other 
disinfectants can destroy the toxins in water.  
The vegetative cells of Clostridium botulinum are 
susceptible to many disinfectants, including 1% sodium 
hypochlorite and 70% ethanol. In contrast, spores are very 
resistant to environmental conditions. The spores of group I 
C. botulinum strains are highly heat resistant; 121°C 
(250°F) for 3 min is used to destroy them during 
commercial canning. Spores of group II strains are often 
damaged by heating to 90°C (194°F) for 10 min, 85°C for 
52 min, or 80°C for 270 min; however, these treatments 
may not be sufficient in some foods. For example, 
lysozyme or other lytic enzymes present in the food may 
help damaged spores germinate. C. botulinum spores can be 
destroyed by autoclaving with moist heat (120°C/ 250°F for 
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Botulism in Humans 
Incubation Period 
The incubation period for foodborne botulism can be a 
few hours to 8 days; most cases become symptomatic in 12 
to 72 hours. Wound infections may become evident within 
a few days to two weeks, with an average incubation period 
of 10 days. The incubation period for adult intestinal 
colonization or infant botulism is unknown; some cases in 
adults have occurred up to 47 days after ingesting food that 
contained the organism. Botulism acquired by inhalation 
usually develops 12 to 36 hours after exposure, but in some 
cases the incubation period may be as long as several days. 
Clinical Signs 
The neurological signs caused by botulinum toxin are 
similar in all forms of the disease. Additional symptoms 
(e.g., gastrointestinal signs in foodborne cases) may also be 
seen in some forms. 
Foodborne botulism 
In foodborne cases, gastrointestinal disturbances such 
as nausea, vomiting and abdominal pain are often the first 
signs. The neurotoxin causes constipation; however, 
diarrhea may also occur with contaminated food. As the 
disease progresses, a symmetric, descending flaccid 
paralysis develops in the motor and autonomic nerves. The 
clinical signs may include blurred or double vision, 
photophobia, drooping eyelids, an expressionless face, 
slurred speech, dysphagia, urine retention, a dry mouth, 
somnolence and muscle weakness. Untreated cases may 
progress to descending paralysis of the respiratory muscles, 
arms and legs. Fatal respiratory paralysis can occur within 
24 hours in severe cases. The pharynx may also collapse 
from cranial nerve paralysis, resulting in respiratory 
dysfunction even if the respiratory muscles are not affected. 
Fever is not usually seen, and cognitive function and the 
senses are almost always unaffected. Death is usually the 
result of respiratory compromise. Recovery can take weeks 
or months. In some cases, survivors report fatigue and 
shortness of breath for years. 
Wound botulism 
Wound botulism is very similar to the foodborne form; 
however, gastrointestinal signs are not usually present and 
patients may have a wound exudate or develop a fever. The 
abscess can also be minor (e.g., a small furuncle or mild 
cellulitis). 
Infant botulism 
Most cases of infant botulism occur in 2-week to 6-
month-old babies, but infants up to a year of age can be 
affected. The first symptom is usually constipation, which 
can persist for several days before flaccid paralysis 
develops. Lethargy, weakness, excessively long sleep 
periods, difficulty in suckling and swallowing, diminished 
gag reflexes, dysphagia with drooling, drooping eyelids and 
poor pupillary light reflexes may also be seen. Some babies 
develop a weak or altered cry. In progressive cases, the 
infant may develop flaccid paralysis; a “floppy head” is 
typical. In severe cases, there may be respiratory 
dysfunction or arrest. Botulism might also be responsible 
for some cases of sudden death in infants. The symptoms 
and severity of this disease vary considerably in different 
babies. In infants that must be hospitalized, supportive care 
is usually required for several weeks; however, some mildly 
affected babies may recover quickly. Relapses are seen 
occasionally after the clinical signs have resolved. 
Intestinal colonization botulism in adults 
The initial symptoms of intestinal colonization 
botulism in adults may include lassitude, weakness and 
vertigo. As the disease progresses, patients may experience 
blurred or double vision, progressive difficulty speaking 
and swallowing, descending flaccid paralysis, and other 
symptoms characteristic of botulism. Abdominal distention 
and constipation may also be seen. Although this form of 
botulism resembles foodborne botulism, the symptoms may 
be prolonged, and relapses may be seen. 
Inhalational botulism 
Inhalational botulism was reported in laboratory 
workers in 1962. It resembled foodborne botulism. 
Communicability 
Person–to–person transmission has not been reported. 
Nevertheless, care should be taken when handling clinical 
samples that may contain botulinum toxin, such as feces, 
gastric contents or body fluids. 
Diagnostic Tests 
Botulism can be tentatively diagnosed by the clinical 
signs and the exclusion of other neurologic diseases. The 
definitive diagnosis relies on identifying the toxin and/ or 
bacterium in feces, blood/ serum, vomitus, gastric aspirates, 
wounds or food samples.  
Botulinum toxin is usually identified with a mouse 
bioassay (the mouse neutralization test), but enzyme-linked 
immunosorbent assays (ELISAs) can also be used. Because 
ELISAs detect both active and inactivated (e.g., heat 
treated) toxins, false positives are possible with this test. 
Only active toxins are detected in mice. Polymerase chain 
reaction (PCR) assays that detect the neurotoxin genes can 
be helpful in identifying C. botulinum; however, some 
genes (silent toxin genes) do not produce active toxin, and 
the results from this assay are confirmed using the mouse 
bioassay. Botulinum toxins can be typed with neutralization 
tests in mice. Serology is not used in diagnosis, as small 
amounts of toxin are involved and survivors rarely develop 
antibodies. 
C. botulinum can be isolated from food or clinical 
samples in anaerobic culture. Heat or ethanol treatment can 
aid recovery in highly contaminated samples such as food 
or feces. These treatments destroy competing 
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microorganisms while allowing clostridial spores to 
survive. The temperature used varies with the group; 80°C 
(176°F) can be used for 10 minutes with group I spores, but 
60°C (140°F) for 10 to 20 minutes is less likely to injure 
group II spores. Some solid media that may be used are 
blood or egg yolk agar, Brucella agar with 5% sheep blood, 
and phenyl ethyl alcohol blood agar. Suitable liquid media 
include chopped-meat-glucose-starch medium, cooked-
meat medium, reinforced clostridial medium, anaerobe 
broth and others. On solid media, C. botulinum colonies are 
usually grayish-white with an irregular edge. The colonies 
are generally beta-hemolytic on blood agar, while on egg 
yolk medium, they usually display surface iridescence that 
extends beyond the colony (lipase positive), and are 
variable for lecithinase activity.. The iridescent zone around 
the colony tends to be larger for C, D and E toxins. (Lipase 
is not specific for C. botulinum; many other Clostridium 
species and other bacteria also produce this enzyme.) The 
stained organism is a Gram positive rod that develops oval 
subterminal spores, especially on media such as chopped 
meat medium incubated for 5 to 7 days at 30°C (86°F). 
Biochemical tests and the detection of volatile metabolic 
products, using gas-liquid chromatography, are helpful in 
identification. The metabolic patterns and other 
characteristics vary with the strain/ group. Definitive 
identification is by demonstration of the toxin. Molecular 
genetic techniques are helpful in tracing the source of an 
outbreak. 
Other diagnostic or clinical tests may be helpful in 
excluding other causes of flaccid paralysis, or supporting 
the diagnosis. Electromyography suggests neuromuscular 
junction blockage, normal axonal conduction, and 
potentiation with rapid repetitive stimulation in the affected 
muscles. 
Treatment 
The binding of botulinum toxins to the presynaptic 
endplates of neurons cannot be reversed; however, axons 
can produce new endplates if the patient can be kept alive 
while they regenerate. Supportive treatment is the 
cornerstone of treatment. Depending on the severity of the 
illness, the respiratory system may need to be sustained 
with oxygen treatment, intubation to keep the airway open 
and/or mechanical ventilation. Supportive care may be 
necessary for up to several weeks or months.  
Botulinum antitoxin, given while the toxin is still 
circulating in the blood, may prevent the disease from 
progressing and decrease the duration of the illness. Once 
the toxin has bound to the nerve endings, antitoxin cannot 
reverse the binding. For this reason, it should be given as 
soon as possible, preferably within the first 24 hours. 
Recent studies and cases suggest that botulinum toxin may 
be found in the circulation for up to 12 days in some 
patients with the foodborne form. How late the 
administration of antitoxin should be considered is 
uncertain. Botulinum antitoxin is usually produced in 
equines, and it can produce adverse effects such as serum 
sickness and sensitization to equine proteins, with the 
possibility of anaphylaxis. Equine source antitoxin is not 
used in infants for this reason; instead, infant botulism can 
be treated with human-derived antitoxin (BIG-IV/ Baby-
BIG). This antitoxin is produced in human donors 
immunized with pentavalent botulinum toxoid (A to E). 
BIG-IV/ Baby-BIG can decrease the hospitalization time 
significantly in infants. It may also be used for older 
patients who cannot tolerate equine serum. In the U.S., 
equine botulinum antitoxin is available from the Centers for 
Disease Control and Prevention (CDC) through state health 
departments, and Big-IV/Baby-BIG is available from the 
California Department of Health Services’ Infant Botulism 
Treatment and Prevention Program. 
Additional treatments depend on the form of the 
disease. In foodborne illness, the amount of toxin in the 
gastrointestinal tract may be reduced with stomach lavage, 
emetics, enemas and/or cathartics. Treatment for wound 
botulism includes surgical debridement of the wound and 
antibiotics. Aerobic conditions may be induced in the 
wound by the use of hydrogen peroxide or hyperbaric 
oxygen therapy. Antibiotics are not recommended in infant 
botulism because the death of the microorganisms might 
release additional toxins from lysed cells. If antibiotics are 
used to treat botulism, drugs that have neuromuscular 
blocking properties, such as aminoglycosides, should be 
avoided. 
Prevention 
Procedures used to heat treat foods in commercial 
canning can destroy C. botulinum spores. The risk of 
botulism can also be reduced by acidification, reductions in 
the amount of moisture in the product, and treatment with 
salt or other compounds known to inhibit the organism’s 
germination and/or growth. Refrigeration can prevent the 
growth of group I strains, but some nonproteolytic group II 
strains may grow at 3-4°C (37-39°F). Foods with “off” 
odors or flavors should not be eaten, but C. botulinum may 
grow without changing the food’s flavor, odor or 
appearance. Preformed toxins in foods can be destroyed by 
boiling the food before serving. 
Because some batches of honey may contain C. 
botulinum spores, this food should not be fed to children 
less than a year of age. To prevent toxins in sick animals 
from affecting people, meat from affected animals is not 
used for food. Whether the toxin can be transported from 
the bloodstream to the milk in ruminants is uncertain, but 
milk from these animals is not allowed to enter the human 
food chain. 
In laboratories, C. botulinum must be handled under 
BSL-2 conditions at a minimum, with BSL-3 precautions 
used for some procedures. Investigational vaccines may be 
available for people who have a high risk of exposure (e.g., 
laboratory workers), and improved vaccines are in 
development. Person-to-person transmission of botulinum 
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has never been described, but precautions should be taken 
to avoid exposure to toxins in body fluids and feces, and 
anyone who has been exposed should remain alert for the 
onset of symptoms.  
Morbidity and Mortality 
Botulism tends to occur as sporadic cases or small 
outbreaks that affect a few people, but large outbreaks can 
also be seen, especially when commercially prepared foods 
are involved. Since 1980, infant botulism has been more 
common than foodborne botulism in the U.S. In 2006, 107 
cases of infant botulism, 19 cases of foodborne botulism 
and 45 cases of wound botulism were reported to the CDC. 
Wound botulism, which was once very rare, has been 
increasing with certain types of drug abuse. 
Untreated cases are often fatal, but supportive care has 
a high success rate when the disease is diagnosed in time. 
Before 1950, the case fatality rate for foodborne botulism 
was 60-70%; currently, it is approximately 5-10% in 
developed countries. Patients in some risk groups, such as 
those older than 60 years of age, have a higher case fatality 
rate. The severity of the illness and time before recovery 
may also be influenced by the dose of the toxin and the 
toxin type. Cases caused by type A toxin tend to be more 
severe than those caused by types B or E. People may also 
have differing sensitivity to the toxin. In one case, a person 
had detectable toxin in the circulation but was 
asymptomatic. 
The case fatality rate for infant botulism is 2%. In 
infants that must be hospitalized, recovery usually requires 
several weeks in the hospital. Antitoxin (Baby-BIG/ BIG-
IV) can significantly decrease this time. Estimates of the 
case-fatality rate for wound botulism vary widely from 1% 
to 15%. 
People who survive botulism do not become immune 
to the disease. Even in the most severe cases, the amount 
of toxin in the body is usually too low to stimulate 
antibody production.  
Botulism in Animals 
Species Affected 
Botulism has been reported in a variety of vertebrates 
including mammals, birds, reptiles and fish. This disease 
occurs in horses, cattle and sheep, as well as in ranched 
mink and foxes. It has also been documented in ferrets, 
laboratory rodents, nonhuman primates, captive mammals 
including lions and sea lions, and wild species such as 
bighorn sheep. Dogs, cats and pigs are relatively resistant to 
the ingestion of this toxin. Nevertheless, there are 
occasional reports of botulism in dogs and pigs, and an 
outbreak was reported in cats that had eaten highly 
contaminated tissues from a pelican. Botulism has also been 
seen in more than a hundred species of birds in 22 families, 
including chickens, pheasants, turkeys, ducks, geese, gulls, 
loons, mergansers, herons, horned grebes and cormorants. 
Outbreaks have been reported in farmed rainbow trout, and 
other fish are susceptible in experimental studies. Botulism 
has also been documented in turtles. 
Incubation Period 
The incubation period can be 2 hours to 2 weeks; in 
most cases, the clinical signs appear in 12 to 48 hours. 
Mink are often found dead within 24 hours of ingesting 
the toxin, and in an outbreak among foxes, the incubation 
time was 8 to 96 hours. In dogs, it is reported to be 24-48 
hours, but in one experiment, dogs fed the toxin became 
ill in 2-4 days.  
Clinical Signs 
Botulism is characterized by progressive motor 
paralysis. In animals, botulism usually affects the hind legs 
first and ascends. In addition to muscle paralysis, animals 
may have difficulty chewing and swallowing, experience 
visual disturbances, and develop generalized weakness and 
incoordination. Autonomic dysfunction may also be seen. 
Death usually results from paralysis of the respiratory 
muscles. Mildly affected animals may recover with minimal 
treatment. 
Ruminants 
Muscle weakness and incoordination, progressing to 
paralysis, is the most apparent sign in ruminants. Weakness 
is seen in the hind legs first. The animal may also have 
difficulty chewing and swallowing food, the tongue may 
protrude, drooling may be seen, and the head may be held 
abnormally low. Restlessness and urine retention can also 
occur. In cattle that become recumbent, the head is often 
turned toward the flank, similarly to a cow with 
hypocalcemia. Laterally recumbent animals are usually 
very close to death. Some sheep and goats have been found 
dead. 
In Germany, a cattle disease characterized by lethargy, 
constipation alternating with diarrhea, edema, decreased 
milk yield, non-infectious chronic laminitis, engorged 
veins, a retracted abdomen and emaciation has been linked 
to the presence of botulinum toxin in the colon and cecum. 
Affected cattle may die unexpectedly. Most cases have 
been seen during the peripartum period, but slow growth 
and wasting was reported in heifers. This disease has been 
tentatively been named “visceral botulism.” 
Horses 
The clinical signs in horses are similar to cattle. They 
may include restlessness, knuckling, incoordination, 
dysphagia, paralysis of the tongue, drooling, decreased 
muscle tone in the tail and/or tongue, and recumbency. The 
muscle paralysis is progressive; it usually begins at the 
hindquarters and gradually moves to the front limbs, head 
and neck. As in other species, paralysis of the respiratory 
muscles can result in death.  
The “shaker foal syndrome” appears to be similar to 
botulism in human infants. The most characteristic signs are 
Botulism 
Last Updated: June 2010 © 2010 page 7 of 11 
a stilted gait, muscle tremors and the inability to stand for 
more than a few minutes. Dysphagia, constipation, reduced 
eyelid, tongue and tail tone, mydriasis, sluggish pupillary 
light reflexes and frequent urination may also be seen. In 
the later stages, foals usually develop tachycardia and 
dyspnea. Without treatment, death from respiratory 
paralysis generally occurs 24 to 72 hours after the initial 
signs. Some foals may be found dead. 
Pigs 
Pigs are relatively resistant to botulism. Reported 
clinical signs include anorexia, refusal to drink, vomiting, 
pupillary dilation and muscle paralysis. 
Foxes and Mink 
During outbreaks of botulism in mink, many animals 
may be found dead, while others have various degrees of 
flaccid paralysis and dyspnea. The clinical picture is similar 
in commercially raised foxes. In some mildly affected 
foxes, only the hind legs are paralyzed. These animals may 
sit and drag the hind part of their bodies. 
Dogs 
Limited studies in dogs suggest that this species is 
relatively insensitive to the ingestion of toxin. Clinical signs 
reported in dogs include vomiting and anterior abdominal 
pain, as well as signs related to the effects of the toxin on 
nerves, such as salivation, incoordination, weakness of the 
hind legs, flaccid paralysis, a depressed gag reflex, and a 
diminished withdrawal reflex and/or pupillary reflexes. 
Congestion of the mucous membranes of the mouth, 
brownish fetid saliva, cheilitis and an unusual, hoarse, 
suppressed bark or whine were reported in some 
experimentally exposed dogs. Some dogs recover, but 
others have died of respiratory failure. 
Cats 
In the single outbreak described in cats, anorexia and 
mild depression were the first signs, followed by flaccid 
paralysis, and in some cases, dyspnea. Similarly to other 
animals, the paralysis was evident first in the hindlegs, 
followed by the forelegs. Some severely affected cats died, 
others recovered spontaneously and rapidly. 
Ferrets 
Experimentally exposed ferrets developed botulism 
signs including weakness, ataxia, ascending paralysis, 
blepharospasm, photophobia and urinary incontinence, with 
death resulting from respiratory failure.  
Sea lions 
Inactivity and dysphagia, followed in some cases by 
unexpected deaths, were reported in sea lions. Although 
some animals appeared to be hungry, chewing fish and 
attempting to swallow, they eventually released the partially 
chewed fish from their mouths. 
 
Birds 
In poultry and waterfowl, botulism is an ascending 
flaccid paralysis and affects the legs first, followed by the 
wings and neck. Mild cases may have only paresis or leg 
paralysis. In gulls, the wing muscles seem to be affected 
before the legs, and delayed or uncoordinated flight may be 
an early sign. Mildly affected gulls are able to stand and 
run, but not fly. Diarrhea with excess urates and paralysis of 
the nictitating membrane have also been reported in some 
species. The feathers of chickens may be ruffled, and they 
may be shed easily when the birds are handled. Birds may 
die from respiratory dysfunction, and waterfowl with 
paralyzed necks may drown. 
Reptiles 
Loss of equilibrium and flaccid paralysis of the legs, 
followed by drowning, have been reported in green sea 
turtles (Chelonia mydas). 
Fish 
Loss of equilibrium and erratic swimming have been 
seen in fish. Increased swimming bursts were the first sign 
of botulism in experimentally exposed rainbow trout 
(Oncorhynchus mykiss). Some fish including rainbow trout, 
walleye (Stizostedion vitreum) yellow perch (Perca 
flavescens), tilapia and coho salmon (Oncorhynchus 
kisutch) may attempt to swim in a head up/ tail down 
orientation, with breaching of the water surface. 
Hyperpigmentation, which can be dramatic, occurs in some 
species. In round goby (Neogobius melanostomas), the first 
sign of botulism was a faint, black band behind the pectoral 
fins, which darkened and spread toward the tail until the 
entire posterior of the fish was darkened. This was followed 
by darkening of the anterior body, until the entire fish was 
almost black. Goby did not develop abnormal swimming 
behavior until the late stages of hyperpigmentation. 
Hyperpigmentation was also an early sign in yellow perch, 
and it has been reported in carp (family Cyprinidae). In 
contrast, decreased color intensity was seen in tilapia and 
rainbow trout in one experiment, while rainbow trout did 
not have obvious changes in pigmentation in another study. 
Similarly to other vertebrates, death occurs in the late stages 
from respiratory compromise. Fish are usually immobile at 
this stage. A few fish with mild clinical signs such as slight 
loss of equilibrium and increased swimming bursts may 
recover completely.  
Communicability 
Botulism is not communicable by casual contact, but 
tissues from dead animals can be toxic if ingested by other 
animals. 
Diagnostic Tests 
Botulism can be difficult to diagnose, as the toxin is 
not always found in clinical samples or the feed. Diagnosis 
is often a matter of excluding other diseases. A definitive 
diagnosis can be made if botulinum toxin is identified in the 
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feed, serum/ blood, stomach, crop or intestinal contents, 
vomitus, feces or tissues. The toxin can usually be found in 
the blood or serum only in the early stages of the disease. 
Botulinum toxin is typically detected with a mouse 
bioassay. ELISAs may also be used, but they detect both 
active and inactivated (e.g., heat treated) toxins, and false 
positives are possible with this test. Botulinum toxins can 
be typed using neutralization tests in mice.  
C. botulinum organisms may also be isolated from the 
feed. In toxicoinfectious botulism, the organism may be 
cultured from the gastrointestinal contents, feces, wounds 
or other tissues. Because healthy animals can have C. 
botulinum spores in the gastrointestinal tract, finding them 
in this location should be interpreted with caution.  
C. botulinum must be isolated in anaerobic culture. 
Heat or ethanol treatment can aid recovery in highly 
contaminated samples such as food or feces. These 
treatments destroy competing microorganisms while 
allowing clostridial spores to survive. Some solid media 
that may be used are blood or egg yolk agar, Brucella agar 
with 5% sheep blood, and phenyl ethyl alcohol blood agar. 
Suitable liquid media include chopped-meat-glucose-starch 
medium, cooked-meat medium, reinforced clostridial 
medium, anaerobe broth and others. On solid media, C. 
botulinum colonies are usually grayish-white with an 
irregular edge. The colonies are generally beta-hemolytic 
on blood agar, while on egg yolk medium, they usually 
display surface iridescence that extends beyond the colony 
(lipase positive), and are variable for lecithinase activity.. 
The iridescent zone around the colony tends to be larger for 
C, D and E toxins. (Lipase is not specific for C. botulinum; 
many other Clostridium species and other bacteria also 
produce this enzyme.) The stained organism is a Gram 
positive rod that develops oval subterminal spores, 
especially on media such as chopped meat medium 
incubated for 5 to 7 days at 30°C (86°F). Biochemical tests 
and the detection of volatile metabolic products, using gas-
liquid chromatography, are helpful in identification. The 
metabolic patterns and other characteristics vary with the 
strain/ group. Definitive identification is by demonstration 
of the toxin. Molecular techniques can be been used for the 
genetic characterization of C. botulinum, and may be 
helpful in determining the source of an outbreak.  
Serology is not used routinely in diagnosis, but 
antibodies to botulinum toxin have been reported in some 
animals that recovered, including horses, cattle and a dog. 
In the dog, paired serum samples revealed a fourfold 
increase in titer. Antibodies to type C and/or D botulinum 
toxin have also been reported in a few golden jackals 
(Canis aureus syriacus) in Israel. 
Treatment 
Treatment is supportive, and may include nursing, 
nutritional support, oxygen and the use of mechanical 
ventilation until the nerve endings regenerate. Mechanical 
ventilation has significantly reduced the death rate in foals, 
but it is impractical and/or unavailable for some animals 
such as adult livestock. In one study, foals that required 
hospitalization could be discharged in approximately 2 
weeks, although they were not fully recovered and stall rest 
or confinement in a small paddock was recommended for 
an additional period. Feed that might be contaminated 
should be removed. Gastric lavage, emetics, cathartics 
and/or enemas may be used to eliminate some of the toxin 
from the gastrointestinal tract, and. activated charcoal or 
other substances may help prevent absorption. Where the 
water supply has high salinity, giving fresh water to prairie 
wildfowl can improve their condition. The supraorbital 
gland in these birds, which functions in osmoregulation, is 
innervated by nerves affected by the toxin. 
Monovalent or polyvalent botulinum antitoxin is 
sometimes used in animals, but it can be expensive, 
especially in adult livestock. Antitoxin against one toxin 
type does not provide any significant cross-protection to 
other types. Decisions on antitoxin treatment must often be 
made before the results from typing are available. The use 
of guanidine hydrochloride, which might help the 
neuromuscular blockade, could also be considered.  
Various treatments including antibiotics and citric acid 
(which chelates the iron needed by C. botulinum to grow) 
have been used in the toxicoinfectious form in birds, with 
varying success. In foals, antibiotics may be given to 
prevent complications such as aspiration pneumonia. If 
antibiotics are used, drugs that have neuromuscular 
blocking properties, such as aminoglycosides, should be 
avoided. 
Some animals with mild disease can survive with 
minimal treatment, or recover on their own. 
Prevention 
In areas where botulism is relatively common, vaccines 
may be used in animals including horses, cattle, sheep, 
goats, mink and birds. Vaccine availability varies with the 
country. In the U.S., commercial vaccines are licensed for 
horses and mink. There is no cross-protection between 
toxin types. Surviving a case of botulism does not protect 
an animal from later exposure to this toxin or eliminate the 
need for vaccination. Foals born to vaccinated dams have 
occasionally developed the shaker foal syndrome. 
During an outbreak, carcasses should be collected to 
prevent animals from eating contaminated tissues or the 
invertebrates that feed on them. Flies should be controlled 
to prevent the occurrence of “toxic” maggots (maggots that 
have ingested botulinum toxin), which may be eaten by 
birds. If possible, litter should also be removed from 
poultry houses in an outbreak. If this cannot be done, 
commercial acid disinfectant or granular sodium bisulfate 
treatment may help suppress the growth of the organism. 
During outbreaks in chickens, it may also be helpful to 
clean and disinfect the environment with products effective 
against spore-forming bacteria. Waterfowl should be chased 
away from contaminated areas when botulism occurs in 
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wild birds. It may also be helpful to stabilize water levels 
(fluctuations have been linked to the proliferation of C. 
botulinum) and eliminate large shallow areas where 
vegetation decays. 
Feed for mink and other ranched animals may be heat 
processed and/or acidified to reduce the risk of botulism. 
Care should be taken in the preparation of feed for 
herbivores. Carcasses should not be allowed to contaminate 
the feed, and silage should be monitored for proper 
acidification. Ruminants should be given feed supplements to 
reduce the incidence of pica when dietary deficiencies exist. 
Morbidity and Mortality 
Outbreaks of botulism occur regularly in wild 
waterfowl and shorebirds. They can be preceded by 
fluctuations in the temperature and/or level of the water, 
which may increase the proliferation of C. botulinum. An 
estimated 10 to 50 thousand wild birds , especially ducks, 
are killed annually. In some large outbreaks of type C 
botulism in western North America, a million or more birds 
may die. Large numbers of gulls and other birds have been 
affected in some other areas, including coastlines in Europe. 
Between 2000 and 2004, more than 10,000 seabirds, mainly 
herring gulls (Larus argentatus) died from type C outbreaks 
in Sweden.  Since 1999, type E botulism affecting large 
numbers of fish-eating birds, such as gulls and loons, has 
been reported regularly in the Great Lakes of North 
America.  
The incidence of botulism in domesticated animals is 
not known with certainty. Carnivores are said to be 
relatively resistant to this disease; however, contaminated 
feed can cause outbreaks affecting hundreds or thousands of 
mink or ferrets. Mink are often vaccinated. Botulism seems 
to be uncommon in ranched foxes, but one outbreak 
resulted in the death of more than 44,000 animals. The 
mortality rate in this outbreak was 22%, and some lots of 
contaminated feed caused the death of more than 40% of 
the foxes. The majority of the animals affected were blue 
foxes (Alopex lagopus) and shadow foxes (a color variant 
of this species), while silver foxes and blue silver foxes, 
which are color variants of Vulpes vulpes, had mortality 
rates of less than 4%. Cats were relatively resistant to the 
ingestion of botulinum toxin in limited experimental 
studies. In the only outbreak reported in this species, the 
dose of toxin appeared to very high. Four of eight cats fed 
the contaminated meat died, but the surviving cats 
recovered quickly. Limited studies in dogs also suggest that 
this species is relatively insensitive to toxin ingestion. In 
one experiment, dogs did not become ill after feeding 
botulinum toxin unless food was withheld first for 48 hours. 
In most parts of the world, botulism seems to be 
relatively uncommon in herbivores; however, it can occur 
more frequently where conditions such as phosphorus-
deficient soils are conducive to this disease. Large numbers 
of animals may be affected in some outbreaks. The prognosis 
is poor in recumbent adult livestock. In cattle, death generally 
occurs within 6 to 72 hours of sternal recumbency. Mortality 
rates of up to 90% have been described in adult horses. 
Toxicoinfectious botulism in foals also had a case fatality 
rate of 90% at one time; however, the use of intensive care, 
mechanical ventilation and antitoxin has significantly 
improved survival. In two recent series, 87.5% of the 
mechanically ventilated foals in one study and 96% of the 
treated foals in another study (some of which did not require 
respiratory support) recovered.  
Outbreaks of botulism in broiler chickens are 
uncommon. These birds become less susceptible to 
botulism with age, and most cases occur in intensively 
reared flocks between the ages of 2 and 8 weeks. The 
mortality rate varies from a few birds to 40% of the flock.  
Among fish, susceptibility seems to vary with the 
species. In one experiment, the mortality rate at various oral 
doses was 92-100% in round goby, 83-92% in walleye, 42-
92% in rainbow trout, and 25%-67% in yellow perch. 
Yellow perch also survived significantly longer than the 
other three species. 
Post Mortem Lesions      Click to view images 
There are no pathognomonic lesions; any lesions are 
usually the result of general muscle paralysis, debilitation, 
the inability to eat and drink, or other secondary effects, and 
may include signs such as congestion in a variety of tissues. 
Respiratory paralysis may cause nonspecific signs in the 
lungs. In shaker foal syndrome, the most consistent lesions 
are excess pericardial fluid with strands of fibrin, 
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